immunity · Mechanism Report
Does elevated pathogen-specific IgG mean current active infection?
An elevated pathogen-specific IgG result alone does not establish current active infection.
This is what AI claimed
Pathogen-specific IgG commonly persists after prior infection or exposure, so an elevated IgG result alone does not establish current active infection.
Executive summary
Pathogen-specific IgG often persists after prior infection or exposure, so it commonly reflects immune history rather than ongoing disease. The mechanism described is continued antibody production by long-lived plasma cells after the acute infection has cleared. Because of this persistence, an isolated elevated IgG result cannot reliably time exposure or confirm that active infection is present.
Verified conclusion
Pathogen-specific IgG is primarily a record of immune exposure rather than a stand-alone marker of active disease. This distinction is especially important when interpreting isolated “elevated” results in older adults, in whom antibody kinetics and clinical presentation may vary.
Persistence and biological basis
- After infection or antigen exposure, pathogen-specific IgG commonly remains detectable after the acute illness has resolved. Long-lived plasma cells—particularly those maintained in bone-marrow survival niches—continue secreting antibody after antigen clearance.
- The initial fall in antibody concentration largely reflects loss of short-lived plasmablasts; a later, slower decline is consistent with long-lived plasma-cell maintenance.
- Persistence varies substantially by pathogen, antigen, host factors, and assay threshold. Reported antiviral-antibody half-lives range from approximately 50 to >200 years; estimated tetanus and diphtheria antibody half-lives are about 11 and 19 years, respectively. In one SARS-CoV-2 cohort, spike-specific IgG remained detectable in 94% at 180 days.
Interpretation for current infection
- An isolated elevated pathogen-specific IgG result does not establish that infection is currently active. It cannot reliably determine the timing of exposure, whether viable pathogen is present, or whether the pathogen explains current symptoms.
- For SARS-CoV-2, CDC and IDSA state that antibody testing should not be used to diagnose current infection. Anti-spike IgG may result from vaccination, infection, or both.
- When active infection is suspected, diagnosis should rely on pathogen-appropriate direct testing—such as NAAT/PCR or antigen testing—interpreted alongside symptoms, timing, and clinical findings. Even NAAT positivity may persist after clinical recovery.
Clinical context
- Serology can have selected roles: paired acute/convalescent samples demonstrating seroconversion or a substantial titre rise may support recent infection, and IgG avidity may occasionally help estimate timing. These approaches are pathogen- and assay-specific.
Bottom line
- Persistent IgG commonly reflects prior infection, exposure, or vaccination; isolated elevation is evidence of immune history, not proof of current active infection.
References
- Persistence of Virus-Specific Antibody after Depletion of Memory B Cells | Journal of Virology — journals.asm.org
- Duration of Humoral Immunity to Common Viral and Vaccine Antigens | NEJM — nejm.org
- Overview of Testing for SARS-CoV-2 | COVID-19 - CDC — cdc.gov
- IDSA Guidelines on the Diagnosis of COVID-19: Serologic ... — idsociety.org
- pmc.ncbi.nlm.nih.gov › articles › PMC4933779Immunoglobulin M for Acute Infection: True or False? - PMC — pmc.ncbi.nlm.nih.gov
- Infectious Diseases Society of America Guidelines on the ... — academic.oup.com
- Mechanisms that determine plasma cell lifespan and the duration of humoral immunity — pmc.ncbi.nlm.nih.gov
- Long-Term B Cell Memory After Infection and Vaccination - PMC — pmc.ncbi.nlm.nih.gov
- SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans — nature.com
See a full patient report verified like this
Book a walkthrough